Affiliation:
1. From the Research Laboratories of CIBA Limited, Pharmaceutical Department, Basle, Switzerland.
Abstract
A short review is given of the development of synthetic angiotensin. Also discussed are enzymic experiments, showing that production of the synthetic substance leads to valyl-5-angiotensin-II, in which all amino acids are completely in the
l
-configuration. Small amounts of diastereoisomers in intermediates, like
l
-valyl-
d
-tyrosyl-
l
-valyl-
l
-histidyl-
l
-prolyl-
l
-phenylalanine which was isolated and identified, are completely eliminated during the synthetic process. Valyl-5-angiotensin II-aspartyl-β-amides are very slowly hydrolyzed in aqueous solution to valyl-5-angriotensin II and a small amount of the heptapeptide, H·Arg-Val-Tyr-Val-His-Pro-Phe·OH, with negligible decrease in pressure activity of the solution.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献